China Medical System Holdings Ltd. engages in the production, marketing, promotion, and sale of drugs. The company employs 6,095 full-time employees The company went IPO on 2010-09-28. The firm's products include Plendil, Ursofalk, Augentropfen Stulln Mono Eye Drops, Hirudoid, Atopic Piel Series and Vmonalisa, among others. Its major marketed products cover the cardio-cerebrovascular, gastroenterology, ophthalmology, dermatology and medical aesthetic fields. The firm distributes its products within domestic market and to overseas markets.
China Medical System Holdings Limited Información sobre dividendos
China Medical System Holdings Limited tiene un dividendo anual de 0.2274 por acción, con un rendimiento del 0.00%. El dividendo se paga semestralmente y la última fecha ex-dividendo fue Aug 29, 2025.